WNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell lines

BACKGROUND: Invasive lobular carcinoma (ILC) of the breast typically presents with clinical biomarkers consistent with a favorable response to endocrine therapies, and over 90 % of ILC cases express the estrogen receptor (ER). However, a subset of ILC cases may be resistant to endocrine therapies, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Sikora, Matthew J., Jacobsen, Britta M., Levine, Kevin, Chen, Jian, Davidson, Nancy E., Lee, Adrian V., Alexander, Caroline M., Oesterreich, Steffi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028957/
https://www.ncbi.nlm.nih.gov/pubmed/27650553
http://dx.doi.org/10.1186/s13058-016-0748-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028957/
https://www.ncbi.nlm.nih.gov/pubmed/27650553
http://dx.doi.org/10.1186/s13058-016-0748-7

Ejemplares similares